122 related articles for article (PubMed ID: 38631183)
1. Increased IL-22 in cerebrospinal fluid of neuro-behçet's disease patients.
Belghith M; Maghrebi O; Ben Laamari R; Hanachi M; Hrir S; Saied Z; Belal S; Driss A; Ben Sassi S; Boussoffara T; Barbouche MR
Cytokine; 2024 Jul; 179():156617. PubMed ID: 38631183
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid IL-10 as an early stage discriminative marker between multiple sclerosis and neuro-Behçet disease.
Belghith M; Bahrini K; Kchaou M; Maghrebi O; Belal S; Barbouche MR
Cytokine; 2018 Aug; 108():160-167. PubMed ID: 29625335
[TBL] [Abstract][Full Text] [Related]
3. B Cells Specific CpG Induces High IL-10 and IL-6 Expression In Vitro in Neuro-Behçet's Disease.
Maghrebi O; Belghith M; Jeridi C; Rachdi A; Fatnassi FN; Saied Z; Belal S; Ben Sassi S; Barbouche MR
Cells; 2022 Apr; 11(8):. PubMed ID: 35455984
[TBL] [Abstract][Full Text] [Related]
4. Discriminative expression of CD39 and CD73 in Cerebrospinal fluid of patients with Multiple Sclerosis and Neuro-Behçet's disease.
Bahrini K; Belghith M; Maghrebi O; Bekir J; Kchaou M; Jeridi C; Amouri R; Hentati F; Belal S; Ben Sassi S; Barbouche MR
Cytokine; 2020 Mar; 130():155054. PubMed ID: 32151963
[TBL] [Abstract][Full Text] [Related]
5. Decreased Level of IL-37 Correlates Negatively with Inflammatory Cytokines in Cerebrospinal Fluid of Patients with Neuro-Behcet's Disease.
Ben Dhifallah I; Borhani-Haghighi A; Hamzaoui A; Hamzaoui K
Iran J Immunol; 2019 Dec; 16(4):299-310. PubMed ID: 31885007
[TBL] [Abstract][Full Text] [Related]
6. Increased T-bet/GATA-3 and ROR-γt /Foxp3 Ratios in Cerebrospinal Fluid as Potential Criteria for Definite Neuro-Behçet's Disease.
Belghith M; Maghrebi O; Cherif A; Bahrini K; Saied Z; Belal S; Sassi SB; Barbouche MR; Kchaou M
J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35956031
[TBL] [Abstract][Full Text] [Related]
7. Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.
Matsushita T; Tateishi T; Isobe N; Yonekawa T; Yamasaki R; Matsuse D; Murai H; Kira J
PLoS One; 2013; 8(4):e61835. PubMed ID: 23637915
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of IL-32 in cerebrospinal fluid of neuro-Behcet disease: Correlation with NLRP3 inflammasome.
Hamzaoui K; Borhani-Haghighi A; Dhifallah IB; Hamzaoui A
J Neuroimmunol; 2022 Apr; 365():577820. PubMed ID: 35123164
[TBL] [Abstract][Full Text] [Related]
9. Evidence of altered Th17 pathway signatures in the cerebrospinal fluid of patients with Guillain Barré Syndrome.
Debnath M; Nagappa M; Dutta D; Talukdar PM; Subbanna M; Shivakumar V; Wahatule R; Sinha S; Bindu PS; Periyavan S; Umamaheswara Rao GS; Kumar MA; Taly AB
J Clin Neurosci; 2020 May; 75():176-180. PubMed ID: 32217048
[TBL] [Abstract][Full Text] [Related]
10. RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behçet's disease.
Hamzaoui K; Borhani Haghighi A; Ghorbel IB; Houman H
J Neuroimmunol; 2011 Apr; 233(1-2):249-53. PubMed ID: 21367463
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis.
Hirohata S; Kikuchi H; Sawada T; Nagafuchi H; Kuwana M; Takeno M; Ishigatsubo Y
Mod Rheumatol; 2012 Jun; 22(3):405-13. PubMed ID: 21935641
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-26 is overexpressed in Behçet's disease and enhances Th17 related -cytokines.
Kaabachi W; Bouali E; Berraïes A; Dhifallh IB; Hamdi B; Hamzaoui K; Hamzaoui A
Immunol Lett; 2017 Oct; 190():177-184. PubMed ID: 28811236
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome.
Hirohata S; Isshi K; Oguchi H; Ohse T; Haraoka H; Takeuchi A; Hashimoto T
Clin Immunol Immunopathol; 1997 Jan; 82(1):12-7. PubMed ID: 9000037
[TBL] [Abstract][Full Text] [Related]
14. Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-Behçet's disease: BAFF is correlated with progressive dementia and psychosis.
Sumita Y; Murakawa Y; Sugiura T; Wada Y; Nagai A; Yamaguchi S
Scand J Immunol; 2012 Jun; 75(6):633-40. PubMed ID: 22340436
[TBL] [Abstract][Full Text] [Related]
15. The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels.
Babaloo Z; Aliparasti MR; Babaiea F; Almasi S; Baradaran B; Farhoudi M
Immunol Lett; 2015 Apr; 164(2):76-80. PubMed ID: 25625963
[TBL] [Abstract][Full Text] [Related]
16. The Cerebrospinal Fluid Presentations of Neuro-Bechet Disease, a Way to Know the Etiopathogenesis and Improve Armamentarium.
Banerjee S; Hamzoui K; Safari A; Borhani-Haghighi A
Iran J Immunol; 2021 Sep; 18(3):170-178. PubMed ID: 34596581
[TBL] [Abstract][Full Text] [Related]
17. Significance of immunoglobulins synthesis with central nervous system involvement in Neuro-Behçet's disease.
Zhan H; Cheng L; Liu Y; Xu H; Feng X; Liu Y; Li H; Li Z; Wang S; Jin H; Zheng W; Hao H; Li Y
Clin Chim Acta; 2024 Jun; 559():119681. PubMed ID: 38643816
[TBL] [Abstract][Full Text] [Related]
18. [Recent aspects of Neuro-Behcet's disease].
Hirohata S
Brain Nerve; 2013 Nov; 65(11):1245-53. PubMed ID: 24200602
[TBL] [Abstract][Full Text] [Related]
19. Anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with neuro-Behçet's syndrome.
Wang CR; Chuang CY; Chen CY
Clin Exp Rheumatol; 1992; 10(6):599-602. PubMed ID: 1483312
[TBL] [Abstract][Full Text] [Related]
20. Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Behçet patients.
Taşçi B; Direskeneli H; Serdaroglu P; Akman-Demir G; Eraksoy M; Saruhan-Direskeneli G
Clin Exp Immunol; 1998 Jul; 113(1):100-4. PubMed ID: 9697991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
